search
medical regulators
Trends
- 1Americans Set to Lose Access to Canadian Prescription Drugs●Americans Are About to Lose Access to Prescriptions from Canada
US Customs is moving to block Americans from importing prescription drugs from Canada, a long-used workaround for high US medication prices, according to the Wall Street Journal. Many patients, particularly retirees and those without adequate insurance, rely on Canadian pharmacies for cheaper drugs like insulin, and the change could raise their costs sharply. Commenters are debating drug pricing policy and whether US regulators will address domestic prices alongside the import crackdown.
- 2
A debate is unfolding over legal accountability when artificial intelligence systems make errors in medical care. As AI tools move into diagnosis, treatment recommendations and clinical workflows, doctors, hospitals and technology developers are all potential defendants. The core question: does responsibility rest with the physician who followed the algorithm, the hospital that deployed it, or the company that built it. Legal frameworks have not kept pace.
- 3Vermont medical education faces new regulatory transparency●Regulators wanted more transparency on Vermont’s medical education. Now they’re getting it.
Regulators in Vermont are pressing for greater transparency in the state's medical education system, and new disclosures are now being made available. The move follows regulatory demands for more openness about how medical training is run and oversighted in the state. The specific details of what is being disclosed remain limited, and reaction from schools or officials is not yet clear.